Next |
home / stock / nbio / nbio message board
Subject | By | Source | When |
---|---|---|---|
News | gladeshawk | investorshub | 06/20/2024 6:15:21 PM |
Nothing has changed. I cannot find any | gladeshawk | investorshub | 05/02/2024 3:52:17 PM |
Anyone know what caused the 33% drop today? | JS016 | investorshub | 04/08/2024 2:45:06 PM |
Perhaps successful collaboration with Hypospray could be expanded | Aa5 | investorshub | 03/27/2024 6:23:53 PM |
Rebounded as expected. Now we need some | gladeshawk | investorshub | 03/27/2024 4:49:44 PM |
Several sites/boards have $NBIO as a BUY. | gladeshawk | investorshub | 03/20/2024 6:56:29 PM |
jedijazz: $NBIO Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Signif | jedijazz | investorshangout | 02/06/2024 5:02:14 PM |
$NBIO starting the day green... UP 15% on | BlazingStocks | investorshub | 02/06/2024 2:37:32 PM |
Thank you for sharing that link to today's | BlazingStocks | investorshub | 02/06/2024 1:55:21 PM |
News: Nascent Biotech and Manhattan BioSolutions Collaborate to | jedijazz | investorshub | 02/06/2024 1:45:04 PM |
$NBIO - Nascent Biotech Receives an Analyst Opinion | BlazingStocks | investorshub | 01/09/2024 3:06:05 PM |
$NBIO News January 09, 2024 Nascent Biotech Receives an | BlazingStocks | investorshub | 01/09/2024 1:55:00 PM |
$NBIO we got premarket news! Nascent Biotech | budfoxfun | investorshub | 12/19/2023 1:16:04 PM |
Nice pop up to .28. News due. | gladeshawk | investorshub | 12/05/2023 3:40:04 PM |
Continues to creep up slowly under the radar | gladeshawk | investorshub | 11/28/2023 8:52:34 PM |
Same here. Close at .18 plus. | gladeshawk | investorshub | 11/13/2023 10:22:59 PM |
So far it's been all good news on | gladeshawk | investorshub | 10/11/2023 6:58:04 PM |
Cancer drug stocks in the news today with | gladeshawk | investorshub | 10/03/2023 1:37:48 PM |
Typical correction in a weak market. | gladeshawk | investorshub | 10/02/2023 8:32:42 PM |
Adding | Impacto | investorshub | 10/02/2023 4:34:28 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...